Conjugated Estrogens Injection and Tofacitinib Extended-Release Tablets
Determining the interaction of Conjugated Estrogens Injection and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: conjugated estrogens
Brand name: Enjuvia, Premarin, Premarin Intravenous, Cenestin
Synonyms: Conjugated estrogens, Estrogens (Conjugated A/Synthetic)
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conjugated Estrogens Injection-Tofacitinib Tablets
- Conjugated Estrogens Injection-Tofranil
- Conjugated Estrogens Injection-Tofranil injection
- Conjugated Estrogens Injection-Tofranil-PM
- Conjugated Estrogens Injection-Tol-Tab
- Conjugated Estrogens Injection-Tolazamide
- Tofacitinib Extended-Release Tablets-Conjugated estrogens Intravenous
- Tofacitinib Extended-Release Tablets-Conjugated estrogens synthetic a
- Tofacitinib Extended-Release Tablets-Conjugated estrogens synthetic b
- Tofacitinib Extended-Release Tablets-Conjugated Estrogens Tablets
- Tofacitinib Extended-Release Tablets-Conjugated estrogens vaginal
- Tofacitinib Extended-Release Tablets-Conray